|Mr. John G. Melo||Pres, CEO & Director||1.8M||N/A||1966|
|Ms. Kathleen Valiasek||Chief Financial Officer||615.47k||N/A||1964|
|Mr. Eduardo Alvarez||Chief Operating Officer||534.26k||N/A||1964|
|Ms. Nicole Kelsey||Gen. Counsel & Sec.||704.16k||N/A||1967|
|Dr. Joel R. Cherry||Pres of R&D||N/A||N/A||1961|
Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable ingredients. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and lubricants for industrial markets; Biofene ingredients for nutraceuticals and vitamins market; and renewable fuels for transportation fuels markets. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. Amyris, Inc. has a collaboration agreement with Yifan Pharmaceutical Co., Ltd. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.
Amyris, Inc.’s ISS Governance QualityScore as of November 1, 2018 is 9. The pillar scores are Audit: 10; Board: 7; Shareholder Rights: 7; Compensation: 9.